Online submission for the upcoming 9th IAU and UCL Annual Conference is now open.
Each abstract will be scored by three reviewers and all abstracts will be accepted on the basis of scientific merit.
15 June 2020
13 July 2020
3 August 2020
21 August 2020
28 August 2020
CALL FOR ABSTRACTS CLOSES
NOTIFICATION TO AUTHORS OF ABSTRACT ACCEPTANCE
AUTHOR ACCEPTANCE DEADLINE
FINAL PROGRAMME RELEASED
PRESENTER REGISTRATION DEADLINE
Abstract Submission Form
There is a maximum of 5 abstract submissions per person allowed.
Rules for Authors
Prior Publication of Material
The IAU and UCL Conference is a forum for the presentation of novel research findings. The work covered by the abstract must not have been published (manuscript or abstract) before September 20th 2020. If the work has been presented at another meeting, the author must disclose when and where it was presented (during the submission process). This is so the Abstract Review Committee can make its decision based on all available details.
The IAU is committed to offering participants an open forum for scientific discussion, wherein all scientists and clinicians are invited to contribute actively. To preserve this valuable environment, the IAU urges all presenters to avoid statements, symbols or other displays that are subjective and unscientific in nature.
Each abstract will be scored by three reviewers. An abstract will be accepted on the basis of scientific merit.
Abstracts may not be revised or resubmitted after the deadline of Monday 15th June 2020.
Please submit abstract withdrawal requests in writing by Monday 15th June 2020.
Change of Presenting Author
Please submit requests in writing by Monday 15th June 2020. After this date, changes will no longer appear in the IAU Abstract Book.
Publication and Copyright
All accepted abstracts will be published in the IAU Abstract Book. Publication of abstracts implies the transfer of copyright of the article to the publisher. This will ensure the widest possible protection and dissemination of information under copyright laws.
Preparation of Abstracts
Abstracts must be written and presented in English. Careful typing and proofreading are essential.
Abstracts should not exceed 350 words. Deduct 50 words for each table or graph included.
To ensure that your abstract receives proper scientific consideration, be sure to note the appropriate abstract theme as indicated below:
Metabolic evaluation and drug treatment
Video: Epidemiology of Urolithiasis
Video: Training and Education
Images, Tables and Graphs
Images are not permitted, as they do not reproduce well. Brief and clear tables or graphs are accepted.
Digital Video Submissions
Content – all digital videos must be recorded in English and have some sound. The opening of the presentation should begin with the title and all the authors’ full names. It is important that all videos must be accompanied by a written abstract.
Length – all videos must not exceed 5 minutes in total length. Any videos that are longer than 5 minutes in duration will be automatically rejected.
Format and Quality – It is important that the overall quality of the video is as high as possible. All submitted videos will be reviewed initially for picture and sound quality. Any videos that have poor sound and picture quality will be excluded from consideration regardless of the quality of content.
File Type and Size – The maximum file limit for video is 350mb. The preferred format for video submission is MP4 as this has the strongest quality. We can also accept PowerPoint presentations with video embedded into the presentation but the file size must not be greater than 350mb. Please consider compressing or “zip” video files before uploading to the Abstract site.
Please use generic drug names in your abstract submission.
Standard abbreviations may be used without definition. Non-standard abbreviations should be kept to a minimum and placed in parentheses after the first use of the word or phrase.
Abstracts must have a short, specific title (no abbreviations) that indicates the nature of the investigation.
Abstracts MUST include the following four distinct sections:
Introduction and Objective
Materials and Methods
Do not include any references, credits or grant support
Abstracts that describe single clinical cases or investigations of compounds that involve inadequate numbers of study subjects, or abstracts that lack quantitative data will not be accepted. Authors should not “split” data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
Abstracts containing identical or nearly identical data submitted from the same institution (and/or individuals) describing the same study population will be disqualified.
Statements such as “results will be discussed” will automatically disqualify the abstract. Reviewers require specific data on which to base their evaluation. Please bear in mind that your abstract will be rated according to the following criteria:
Is the design of the study valid?
Are the methods appropriate?
What is the significance of the results?
Is the event described in the case report significant?
Any human experimentation conducted as part of the submitted abstract(s) must follow the protocol approved by the institutional or local committee on ethics in human investigation, or, if no such committee exists, the investigation should have been conducted in accordance with the principles of the World Medical Association’s Helsinki Declaration. The Scientific Committee may inquire further into ethical aspects when evaluating the abstract(s).